Literature DB >> 17448022

Coeliac disease: a histological follow-up study.

M T Bardella1, P Velio, B M Cesana, L Prampolini, G Casella, C Di Bella, A Lanzini, M Gambarotti, G Bassotti, V Villanacci.   

Abstract

AIMS: To assess the histological response to a gluten-free diet (GFD) in a series of coeliac patients in clinical remission, of different ages and with varying degrees of mucosal damage at diagnosis. METHODS AND
RESULTS: Biopsy samples from 249 coeliac patients (F 165, M 84) were analysed basally and after clinical and biochemical remission following a GFD. All patients showed an improvement in mucosal findings after starting a GFD, but complete histological normalization was observed in 74.1% of paediatric cases (diagnosed before 14 years of age) and in only 17.5% of adults. Statistical analysis showed that sex, the clinical picture at diagnosis and the length of time between biopsy at the time of diagnosis and on a GFD were not related to histological normalization. In contrast, the age at diagnosis was statistically significantly related to it (P < 0.0001). In addition, the presence/absence of Helicobacter pylori was independent of the normalization of the duodenal mucosa.
CONCLUSIONS: In clinical practice the criteria for diagnosis of coeliac disease are sufficiently standardized, whereas for follow-up they are less well defined. We suggest that in order to compare the results from different studies, it should be stated whether remission after treatment is based on clinical or histological criteria or both.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448022     DOI: 10.1111/j.1365-2559.2007.02621.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  42 in total

Review 1.  Celiac disease: risk assessment, diagnosis, and monitoring.

Authors:  Mala Setty; Leonardo Hormaza; Stefano Guandalini
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 2.  Histological healing in inflammatory bowel disease: a still unfulfilled promise.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Karel Geboes; Giovanni Casella; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

3.  Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials.

Authors:  Matthew Siegel; Mitchell E Garber; Andrew G Spencer; Wendy Botwick; Pawan Kumar; Robert N Williams; Kenji Kozuka; Revati Shreeniwas; Vijaya Pratha; Daniel C Adelman
Journal:  Dig Dis Sci       Date:  2011-09-23       Impact factor: 3.199

Review 4.  Serum markers in the clinical management of celiac disease.

Authors:  Marlou Adriaanse; Daniel A Leffler
Journal:  Dig Dis       Date:  2015-04-22       Impact factor: 2.404

Review 5.  The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis.

Authors:  Carolina Ciacci; Paul Ciclitira; Marios Hadjivassiliou; Katri Kaukinen; Jonas F Ludvigsson; Norma McGough; David S Sanders; Jeremy Woodward; Jonathan N Leonard; Gillian L Swift
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

6.  Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.

Authors:  Alberto Rubio-Tapia; Mussarat W Rahim; Jacalyn A See; Brian D Lahr; Tsung-Teh Wu; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2010-02-09       Impact factor: 10.864

7.  Persistent mucosal damage and risk of fracture in celiac disease.

Authors:  Benjamin Lebwohl; Karl Michaëlsson; Peter H R Green; Jonas F Ludvigsson
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

Review 8.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

9.  Predictors of persistent villous atrophy in coeliac disease: a population-based study.

Authors:  B Lebwohl; J A Murray; A Rubio-Tapia; P H R Green; J F Ludvigsson
Journal:  Aliment Pharmacol Ther       Date:  2014-01-16       Impact factor: 8.171

10.  Duodenal biopsy may be avoided when high transglutaminase antibody titers are present.

Authors:  Santiago Vivas; Jose G Ruiz de Morales; Sabino Riestra; Laura Arias; Dolores Fuentes; Noemi Alvarez; Sara Calleja; Mercedes Hernando; Blanca Herrero; Javier Casqueiro; Luis Rodrigo
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.